Jean - Marc Le Doussal

Jean-Marc Le Doussal is an accomplished entrepreneur and biotech leader with extensive experience in the development of advanced therapeutics. As the Founder and CEO of Remora Biotech since January 2011, Jean-Marc has built a portfolio of companies focused on immunology and biotherapeutics. Currently serving as Founder and Chairman at Cellula Therapeutics, Jean-Marc is dedicated to developing next-generation CAR-T therapies for brain cancer. Additionally, Jean-Marc is the Founder and Chairman of OGD2 Pharma, specializing in anticancer immunotherapies, and Activen SA, which innovates miniproteins for the dermo-cosmetic industry. With past leadership roles including Founder and Chairman at Fastox Pharma and ATLAB Pharma, as well as a background in consultancy and research, Jean-Marc combines expertise in immunology and entrepreneurial acumen. Jean-Marc holds a Master's degree in Engineering from École Polytechnique, a PhD in Immunology from Aix-Marseille University, and two Executive MBAs from EPFL, emphasizing management, entrepreneurship, and innovation.